Results – TransplantID

Measles Guidance Document for the Transplant Community

AST, I. D. C. of - 2025, May 31 - American Society of Transplantation

Make a difference in the field of transplantation by donating to support our cause.

Coronavirus Disease 2019 (COVID-19): Frequently Asked Questions for Transplant Candidates, Recipients, and Care Givers

AST - 2022, October 12

Information regarding COVID-19 continues to change rapidly. This document will be updated with new information whenever possible. Please contact your transplant center with specific questions or concerns. Human coronaviruses are common viruses that cause the common cold, and do not usually cause serious symptoms. A novel coronavirus named SARS-CoV-2 causes the disease called Coronavirus disease 2019 (COVID-19). This coronavirus appeared in December 2019 and quickly spread all over the...

American Society of Transplantation: COVID-19 Resources

AST - 2022, June 30

Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice

Danziger-Isakov, L., Kumar, D., & Practice, T. A. I. C. of - 2019 - Clinical Transplantation, 33(9), e13563

These updated guidelines of the AST IDCOP review vaccination of solid organ transplant candidates and recipients. General principles of vaccination as well as the use of specific vaccines in this population are discussed. Vaccination should be reviewed in the pre-transplant setting and appropriate vaccines updated. Both inactivated and live vaccines can be given pre-transplant. The timing of vaccination post-transplant should be taken into account. In the post-transplant setting, inactivated...

BK polyomavirus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Hirsch, H. H., Randhawa, P. S., & Practice, A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13528

The present AST-IDCOP guidelines update information on BK polyomavirus (BKPyV) infection, replication, and disease, which impact kidney transplantation (KT), but rarely non-kidney solid organ transplantation (SOT). As pretransplant risk factors in KT donors and recipients presently do not translate into clinically validated measures regarding organ allocation, antiviral prophylaxis, or screening, all KT recipients should be screened for BKPyV-DNAemia monthly until month 9, and then every 3...

Human herpesvirus 6, 7, and 8 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Pellett Madan, R., Hand, J., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13518

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of HHV-6A, HHV-6B, HHV-7, and HHV-8 in the pre- and post-transplant period. The majority of HHV-6 (A and B) and HHV-7 infections in transplant recipients are asymptomatic; symptomatic disease is reported infrequently across organs. Routine screening for HHV-6 and 7 DNAemia is not recommended in asymptomatic patients, nor is...

Human parvovirus B19 in solid organ transplantation: Guidelines from the American society of transplantation infectious diseases community of practice

Eid, A. J., Ardura, M. I., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13535

Clinical manifestations of human parvovirus B19 infection can vary widely and may be atypical in solid organ transplant (SOT) recipients. However, disease is apparent when there is destruction of erythrocyte progenitor cells leading to severe acute or chronic anemia with lack of an appropriate reticulocyte response in the setting of active parvovirus B19 infection. Serology may not reliably establish the diagnosis. High-level viremia is more likely to be associated with symptomatic disease....

Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Pergam, S. A., Limaye, A. P., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13622

These updated guidelines from the American Society of Transplantation Infectious Diseases Community of Practice review the diagnosis, prevention, and management of varicella zoster virus (VZV) in the pre- and post-transplant period. Primary varicella is an uncommon complication post-solid-organ transplant (SOT), except among pediatric transplant patients and those seronegative for VZV. As the majority of SOT recipients are seropositive for VZV, herpes zoster (HZ) occurs frequently following...

Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Chin-Hong, P. V., Reid, G. E., & Practice, the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13590

These guidelines from the American Society of Transplantation Infectious Diseases Community of Practice update the epidemiology and management of human papillomavirus (HPV) infections in organ transplant recipients. HPV is one of the most common sexually transmitted infections and is associated with cancers of the anogenital region. Increasing evidence suggests an association with head and neck cancers as well. Solid organ transplant recipients have a higher risk of HPV infection than the...

Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Lee, D. H., Zuckerman, R. A., & Practice, on behalf of the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13526

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of HSV in the pre- and post-transplant period. A majority of transplant recipients are seropositive for HSV-1 or 2. Compared with immunocompetent persons, SOT recipients shed HSV more frequently, have more severe clinical manifestations, and are slower to respond to therapy. Most HSV infection is diagnosed on clinical grounds,...

Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Florescu, D. F., Schaenman, J. M., & Practice, on behalf of the A. I. D. C. of - 2019 - Clinical Transplantation, 33(9), e13527

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of adenovirus infections after solid organ transplantation. Adenovirus is an important cause of infectious complications in both stem cell transplant and SOT patients, causing a range of clinical syndromes including pneumonitis, colitis, and disseminated disease. The current update of the guidelines highlights that adenovirus...

Human Papillomavirus in Solid Organ Transplantation: Human Papillomavirus in Solid Organ Transplantation

Chin-Hong, P. V., Kwak, E. J., & the AST Infectious Diseases Community of Practice - 2013 - American Journal of Transplantation, 13(s4), 189–200

Your search

Results 12 resources

Filter by our tag

GUIDELINES

CORE CURRICULUM

ORGANISMS

PREVENTION